Tirzepatide
GLP-1/GIP Receptor Agonist Peptide
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that has become one of the most studied peptides in modern metabolic research. It simultaneously targets two incretin pathways, making it a subject of intense scientific interest for its role in glucose metabolism and body composition. Researchers continue to investigate its unique dual mechanism, which distinguishes it from single-agonist compounds.
Aliases: GIP/GLP-1 dual agonist, Mounjaro, Zepbound
- Research score
- 10/10
Key fact
First dual GIP/GLP-1 receptor agonist. Up to 22.5% body weight loss in Phase 3 trials (SURMOUNT-1). FDA-approved as Mounjaro and Zepbound.
Mechanism
Tirzepatide is a 39-amino acid acylated peptide with a C20 fatty diacid moiety enabling once-weekly dosing. It acts as an imbalanced dual agonist: full potency at the GIP receptor (equal affinity to native GIP) and approximately 5-fold weaker affinity at the GLP-1 receptor vs native GLP-1. This imbalanced pharmacology drives unique signaling bias. Activates cAMP accumulation through both GIPR and GLP-1R, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing food intake via central appetite circuits.
Evidence note
Established — Robust Phase 3 data (SURPASS 1-5, SURMOUNT 1-4), FDA-approved as Mounjaro (T2D) and Zepbound (obesity). Thousands of participants across RCTs.
Community evidence
- Source window English Reddit Updated 12 Aug 2026 · 6-month window
- Coverage confidence Low Confidence in the available community sample
- Distribution Pending Not enough data for a distribution.
Selected reports
-
4mo agor/GLP1ResearchTalk · Comment
Yep, I just finished 5 weeks on 10mg and feel comfy. I’m still losing, so I think 7.5 will be my maintenance. 3
-
6 months agor/tirzepatidecompound · Post
I get that tirz is tirz, but I’ve been on it for about 8 months now with pretty manageable side effects. This month is my first time trying ProRx, and wow… it’s hitting completely different. I’ve been feeling pretty sick and the side effects have been way more intense than
-
4mo agor/GLP1microdosing · Comment
... Hi everyone. This is my absolute first time post on any Reddit thread…trumpet fanfare. ;) so I am 52, 48 years old, definitely perimenopausal, and in February I started at 2.5 mg of tirzepatide. After the second week it became clear that the side effects were no go. I was
Based on 4 qualifying reports from 4 threads. 37 candidates excluded as duplicates, promotion, deleted content, or lacking concrete personal experience. Reddit self-reports are not medical evidence or proof of causation.
Studies
The Role of Tirzepatide in Management of T2D: SURPASS Trials
39-amino acid synthetic peptide; dose-dependent weight loss up to 12.4%
Open source · PMID 33325008Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for T2D
First dual agonist approved; superior HbA1c and weight reduction vs semaglutide
Open source · PMID 36050763Tirzepatide for obesity in adults without diabetes
Up to 22.5% body weight loss at 15mg dose over 72 weeks
Open source · PMID 37385275
FAQ
What happens when you stop taking it?
Clinical data shows weight regain in approximately 82% of participants after discontinuation. Most researchers view it as an ongoing protocol rather than a short cycle.
Is tirzepatide the same as Mounjaro?
Tirzepatide is the active compound. Mounjaro is the brand name for type 2 diabetes, Zepbound for obesity. Research-grade tirzepatide is the same molecule.
How does tirzepatide compare to semaglutide?
Tirzepatide is a dual agonist (GIP + GLP-1) while semaglutide targets only GLP-1. Clinical trials show tirzepatide produces roughly 50% more weight loss. It also tends to have a different side effect profile.
For research and educational use only. This content is not medical advice.